Astrid De Leeuw
Overview
Explore the profile of Astrid De Leeuw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
582
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirchheiner K, Zaharie A, Smet S, Spampinato S, Chargari C, Haie-Meder C, et al.
Int J Radiat Oncol Biol Phys
. 2024 Sep;
121(2):452-464.
PMID: 39278418
Purpose: The purpose of this study was to provide risk estimations for vaginal morbidity with regard to vaginal dilation (summarizing the use of dilators and/or sexual activity) in patients with...
2.
Ecker S, Kirisits C, Schmid M, Knoth J, Heilemann G, De Leeuw A, et al.
Radiother Oncol
. 2023 Jun;
186:109748.
PMID: 37330055
Purpose: To develop a novel decision-support system for radiation oncology that incorporates clinical, treatment and outcome data, as well as outcome models from a large clinical trial on magnetic resonance...
3.
Ecker S, Kirisits C, Schmid M, De Leeuw A, Seppenwoolde Y, Knoth J, et al.
Radiother Oncol
. 2023 Feb;
182:109524.
PMID: 36764459
Purpose: To develop and implement a software that enables centers, treating patients with state-of-the-art radiation oncology, to compare their patient, treatment, and outcome data to a reference cohort, and to...
4.
Spampinato S, Tanderup K, Lindegaard J, Schmid M, Sturdza A, Segedin B, et al.
Radiother Oncol
. 2023 Jan;
181:109501.
PMID: 36720348
Purpose: To quantify the association of persistent morbidity with different aspects of quality of life (QOL) in locally advanced cervical cancer (LACC) survivors. Material And Methods: Longitudinal outcome from the...
5.
Schmid M, Lindegaard J, Mahantshetty U, Tanderup K, Jurgenliemk-Schulz I, Haie-Meder C, et al.
J Clin Oncol
. 2023 Jan;
41(10):1933-1942.
PMID: 36599120
Purpose: To report clinical and treatment characteristics, remission and failure patterns, and risk factors for local failure (LF) from the EMBRACE-I study. Materials And Methods: EMBRACE-I was a prospective, observational,...
6.
Reijtenbagh D, Godart J, De Leeuw A, Seppenwoolde Y, Jurgenliemk-Schulz I, Mens J, et al.
Radiother Oncol
. 2022 Feb;
170:169-175.
PMID: 35219799
Background And Purpose: Image-guided adaptive brachytherapy (IGABT) is a key component in the treatment of cervical cancer, but the nature of the clinical workflow makes it vulnerable to suboptimal plans,...
7.
Kirchheiner K, Smet S, Spampinato S, Jensen N, Vittrup A, Fokdal L, et al.
Brachytherapy
. 2020 Sep;
19(6):837-849.
PMID: 32978080
In 2008, the GEC ESTRO Gyn network launched the first multiinstitutional, observational, and prospective international study on MRI-guided brachytherapy in locally advanced cervical cancer patients (EMBRACE-I). EMBRACE-I was followed by...
8.
Tanderup K, Nesvacil N, Kirchheiner K, Serban M, Spampinato S, Jensen N, et al.
Semin Radiat Oncol
. 2020 Aug;
30(4):311-327.
PMID: 32828387
The last 2 decades have witnessed the development and broad adoption of image-guided adaptive brachytherapy (IGABT) combined with radiochemotherapy in patients with locally advanced cervical cancer. A variety of brachytherapy...
9.
Tan L, Tanderup K, Kirisits C, Mahantshetty U, Swamidas J, Jurgenliemk-Schulz I, et al.
Brachytherapy
. 2020 Aug;
19(6):827-836.
PMID: 32811761
Image-guided adaptive brachytherapy (IGABT) has been shown to improve local/regional control and survival for cervix cancer patients while reducing morbidity. However, the technique is complex involving several conceptual, methodological, and...
10.
Serban M, Kirisits C, De Leeuw A, Potter R, Jurgenliemk-Schulz I, Nesvacil N, et al.
Int J Radiat Oncol Biol Phys
. 2020 Feb;
106(5):1052-1062.
PMID: 32007365
Purpose: The aim of this study was to investigate the influence of brachytherapy technique and applicator type on target dose, isodose surface volumes, and organ-at-risk (OAR) dose. Methods And Materials:...